Health & Wellbeing
On these pages you'll find everything from devices designed to give you a better night's sleep to the latest work being done to tackle the obesity epidemic. Live long and prosper!
-
Experimental ALS drug prolongs survival in Phase 2 human trial
An experimental drug has been shown to slow the progression and prolong survival of patients suffering from the neurodegenerative disease ALS. With Phase 2 human trials complete, the company developing the treatment is working to accelerate its approval. -
New evidence affirms apathy is an early sign of dementia
A growing body of study is beginning to suggest severe apathy in older adults is an early sign of dementia. New research is now presenting one of the first longitudinal studies to show apathy could be an early symptom of cognitive decline. -
Machine learning predicts schizophrenia relapses using smartphone data
A pair of studies are showing how passive smartphone data can be used to predict relapse episodes in schizophrenia patients. The research used machine learning to analyze behavioral data and predict schizophrenic relapses up to one month before they occurred. -
Study predicts over 400,000 excess pandemic deaths in US by end of 2020
New research tracking total all-cause death rates in the US has found 20 percent more people have died in 2020 compared to prior year averages. And, even more strikingly, only two-thirds of those excess deaths can be directly attributed to COVID-19. -
Coronavirus can survive on banknotes for 28 days, but what does that mean?
A new study measuring the survival rates of SARS-CoV-2 on various surfaces found the virus can survive up to 28 days on glass and banknotes. However, experts urge caution as these results do not translate to conditions influencing real-world transmission of COVID-19. -
Gait-analyzing wearable sensors could save users a visit to the clinic
Presently, in order to get a detailed analysis of their walking gait, patients have to travel to a clinic where they walk on a pressure-sensitive mat. That could be about to change, though, thanks to a new wearable system. -
What do we know about Trump's experimental COVID-19 "cure"?
In a recent video message Donald Trump attributed his rapid COVID-19 recovery to a new experimental therapy he called ‘Regeneron’ and subsequently referred to it as a “cure”. What do we know about this new experimental drug? Is it safe? And what does it actually do? -
Breakaway exercise bike folds down small when not needed
Exercise bikes may offer a great form of exercise, but the things can get in the way. The Breakaway Bike is designed with that in mind, as it folds down into a package that's about the size of a carry-on bag. -
Ultraviolet LEDs proposed for skin-safe vitamin D production
Even though we're warned about the harmful effects of ultraviolet (UV) rays in sunlight, they're essential for the production of vitamin D in the body. Now, scientists are claiming that UV LEDs could serve as a safe alternative to sunlight. -
New study recommends drinking coffee after breakfast, and not before
A new study is suggesting a strong coffee first thing in the morning, especially following a night of disrupted sleep, can impair the body’s glucose response. The researchers recommend coffee should consumed in the morning after food, and not before. -
Intermittent 16:8 fasting doesn't work for weight loss, UCSF study claims
A new study is challenging popular dietary dogma by suggesting a common type of intermittent fasting does not work for weight loss. The clinical trial found the 16:8 method of eating no more effective for losing weight than eating throughout the day. -
Trial finds introducing gluten into diet early may prevent celiac disease
The results of a clinical trial find introducing gluten into a baby's diet from the age of four months may reduce their risk of developing celiac disease. The researchers stress larger trials are necessary before any broad dietary recommendations are suggested.
